Next Article in Journal
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
Next Article in Special Issue
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice
Previous Article in Journal
Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(6), 1270; https://doi.org/10.3390/pharmaceutics14061270
Action Date Notes Link
article xml file uploaded 15 June 2022 11:57 CEST Original file -
article xml uploaded. 15 June 2022 11:57 CEST Update https://www.mdpi.com/1999-4923/14/6/1270/xml
article pdf uploaded. 15 June 2022 11:57 CEST Version of Record https://www.mdpi.com/1999-4923/14/6/1270/pdf
article html file updated 15 June 2022 11:58 CEST Original file -
article html file updated 12 August 2022 20:30 CEST Update https://www.mdpi.com/1999-4923/14/6/1270/html
Back to TopTop